Pages that link to "Q130138262"
Jump to navigation
Jump to search
The following pages link to Jessica Darenberg (Q130138262):
Displaying 25 items.
- Evolutionary pathway to increased virulence and epidemic group A Streptococcus disease derived from 3,615 genome sequences (Q33674247) (← links)
- Variations in emm type among group A streptococcal isolates causing invasive or noninvasive infections in a nationwide study (Q33884965) (← links)
- Intravenous Immunoglobulin Adjunctive Therapy in Sepsis, with Special Emphasis on Severe Invasive Group A Streptococcal Infections (Q35585106) (← links)
- Pneumococcal Carriage in Children under Five Years in Uganda-Will Present Pneumococcal Conjugate Vaccines Be Appropriate? (Q36187591) (← links)
- Epidemiology of severe Streptococcus pyogenes disease in Europe. (Q36747672) (← links)
- Effects of PCV7 and PCV13 on invasive pneumococcal disease and carriage in Stockholm, Sweden (Q36762692) (← links)
- Bacterial phenotype variants in group B streptococcal toxic shock syndrome (Q37133323) (← links)
- Clinical and microbiological characteristics of severe Streptococcus pyogenes disease in Europe (Q37156883) (← links)
- Soluble M1 protein of Streptococcus pyogenes triggers potent T cell activation (Q40075380) (← links)
- Unaltered pneumococcal carriage prevalence due to expansion of non-vaccine types of low invasive potential 8years after vaccine introduction in Stockholm, Sweden (Q40595069) (← links)
- Clinical manifestations of invasive pneumococcal disease by vaccine and non-vaccine types (Q41697981) (← links)
- Comparison of the Impact of Pneumococcal Conjugate Vaccine 10 or Pneumococcal Conjugate Vaccine 13 on Invasive Pneumococcal Disease in Equivalent Populations (Q41987255) (← links)
- Clinical efficacy of polyspecific intravenous immunoglobulin therapy in patients with streptococcal toxic shock syndrome: a comparative observational study (Q42210564) (← links)
- Reply to Arends and Harkisoen (Q43077920) (← links)
- Intravenous immunoglobulin G therapy in streptococcal toxic shock syndrome: a European randomized, double-blind, placebo-controlled trial (Q43470558) (← links)
- Contribution of host, bacterial factors and antibiotic treatment to mortality in adult patients with bacteraemic pneumococcal pneumonia (Q43915808) (← links)
- Improvement of CRB-65 as a prognostic scoring system in adult patients with bacteraemic pneumococcal pneumonia (Q44197507) (← links)
- Increase in serious infections due to group A streptococci (Q44597610) (← links)
- Differences in potency of intravenous polyspecific immunoglobulin G against streptococcal and staphylococcal superantigens: implications for therapy of toxic shock syndrome (Q48003602) (← links)
- Reply to Theilacker, et al. (Q49617785) (← links)
- Molecular and clinical characteristics of invasive group A streptococcal infection in Sweden (Q51103787) (← links)
- A food-borne streptococcal sore throat outbreak in a small community (Q64129651) (← links)
- The epidemiology of pneumococcal infections--the Swedish experience (Q64131662) (← links)
- Severe group A streptococcal infections in Uppsala County, Sweden: clinical and molecular characterization of a case cluster from 2006 to 2007 (Q84921801) (← links)
- Reduced In Vitro Susceptibility of Streptococcus pyogenes to β-Lactam Antibiotics Associated with Mutations in the pbp2x Gene Is Geographically Widespread (Q93037638) (← links)